ScoutQuest4 Nov 2026
Evonile Pharma500672Rights issue announcement

Board approves rights issue of partly paid equity shares up to ₹ 9,000 million

Board meeting of Evonile Pharma held on November 04, 2026.

By ScoutQuest · · 1 min read

Aggregate Rights Issue Amount
up to ₹ 9,000 million (Rupees Nine Thousand Million only)
Board Meeting Date
November 04, 2026
Instrument
rights issue of partly paid-up equity shares

What the board approved

Who fixes the remaining terms

A Rights Issue Committee has been authorised to decide the other terms and conditions of the rights issue. This includes the record date, the issue price, the right entitlement ratio and other related matters, within applicable laws including the SEBI ICDR Regulations.

Other items cleared at the meeting

What partly paid-up shares mean for a shareholder

In a partly paid-up issue, the shareholder pays for the shares in stages rather than all at once. The payment schedule approved by the board sets the timing and amounts of these instalments. The issue price and entitlement ratio, once decided, will determine how many shares an eligible shareholder can apply for and at what cost.

Key figure to track

More numbers
  • Aggregate size of the rights issue₹ 9,000 million
Source: BSE · 4 Nov 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev